EntryPoint Capital »

Abcellera Biologics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $305k 117k 2.60

More positions owned by EntryPoint Capital

Tetra Tech (TTEK)
Photronics (PLAB)
Maximus (MMS)
Matrix Service Company (MTRX)
Sun Communities (SUI)
Guardant Health (GH)
Live Nation Entertainment (LYV)
RBC Bearings Incorporated (RBC)
Edwards Lifesciences (EW)
AES Corporation (AES)
Hamilton Lane Cl A (HLNE)
Strategic Education (STRA)
Jack Henry & Associates (JKHY)
Powell Industries (POWL)
American Woodmark Corporation (AMWD)

View all positions for EntryPoint Capital

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
Prosight Management
Ubs Global Asset Management Americas
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
Renaissance Technologies
Two Sigma Investments
Tang Capital Management
Federated Investors
Two Sigma Advisers
Guardian Capital Advisors
Citadel Advisors

View all funds holding Abcellera Biologics